Skip to main content

Table 2 Effect of BV and BPF treatment on acrylamide and chips administration on the plasma GOT (U/ml), GPT (U/ml), and albumin (g/dl) for 60 day

From: Counter effect of bee venom and its extracted bradykinin-potentiating factor on acrylamide and chips administration-induced complications in the liver and kidney of male mice

  Cont. Acr. Chip. BV BPF Acr + BV Acr + BPF Chip + BV Chip + BPF
GOT
Mean ± SE
94.9 ± 3.72 160.16 ± 3.29a** 178.4 ± 15.50a** 99.6 ± 9.74b**, c* 103.8 ± 9.14b**c* 110.9 ± 6.25b**, c* 103.5 ± 10.39b**, c* 103.8 ± 6.20b**, c* 106.6 ± 8.80b**, c*
% of change 1 + 68.76 + 87.98 + 4.95 + 9.37 + 16.85 + 9.06 + 9.37 + 12.32
2 + 11.38 − 37.81 − 35.18 − 30.75 − 35.37 − 35.18 − 33.44
3 − 44.17 − 41.81 − 37.83 − 41.98 − 41.81 − 40.24
GPT
Mean ± SE
110.4 ± 6.73 178.6 ± 11.41a** 143.8 ± 4.35a*, b* 113 ± 7.43b*, c* 122.8 ± 4.58b*, c* 97.8 ± 8.97b**, c* 125 ± 4.53b*, c* 116.2 ± 7.61b*, c* 114.6 ± 7.11b*, c*
% of change 1 + 61.7 + 30.25 + 2.35 + 11.23 − 11.41 + 13.22 + 5.25 + 3.80
2 − 19.48 − 36.73 − 31.24 − 45.24 − 30.01 −34.93 − 35.83
3 − 21.41 − 14.60 − 31.98 − 13.07 − 19.19 − 20.30
Albumin
Mean ± SE
3.696 ± 0.22 2.586 ± 0.036a* 2.968 ± 0.28 3.476 ± 0.09b** 3.606 ± 0.19b** 3.852 ± 0.11b**, c* 3.732 ± 0.138b**, c* 3.63 ± 0.21b* 3.82 ± 0.17b**, c*
% of change 1 − 30.08 − 19.78 − 5.95 − 2.43 + 4.33 + 1.08 − 1.62 3.52
2 + 14.77 + 34.41 + 39.44 + 48.95 + 44.31 + 40.37 + 47.71
3 + 17.11 + 21.49 + 29.78 + 25.74 + 22.30 + 28.70
  1. Significance difference between control and treated groups. n = 5. % of change: (1) from control, (2) from acrylamide, (3) from chips
  2. *P < 0.05 significant, **P < 0.001 highly significant
  3. aSignificance difference to control
  4. bSignificance difference to acrylamide
  5. cSignificance difference to chips